• Shez Partovi

Prior to the pandemic, the healthcare, life sciences, and genomics industries were already looking for ways to use technology and the cloud to advance medical research, drug development, and the entire patient experience, with the goal of improving patient care, advancing precision medicine, and bringing new therapeutics to market faster. What COVID-19 did was simply accelerate these forces.
Read more...